Portfolio company
Novadip
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops regenerative tissue products to treat large bone defects and spinal fusion for patients with limited treatment options.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Novadip Biosciences
This company develops regenerative tissue products to treat patients with large bone defects, non-union fractures and spinal fusion requirements.
EpiBone
This company grows personalized bone and cartilage grafts from a patient's own stem cells to treat individuals with skeletal defects.
Kuros Biosciences
This company develops bone graft technologies and orthobiologics for surgeons and hospitals to facilitate bone healing and tissue regeneration.
Neuroplast
This company develops autologous stem cell therapies to treat patients with neurodegenerative diseases including spinal cord injuries and amyotrophic lateral sclerosis.
NovaGo Therapeutics
This clinical-stage biotechnology company develops human antibody therapeutics to promote nerve regeneration for patients with spinal cord injuries and strokes.
Bonesupport
This company develops and manufactures injectable bioceramic bone graft substitutes for surgeons and healthcare providers to treat bone voids, defects and infections.
IBI
This company develops and manufactures biomimetic bone substitutes for orthopaedic and dental surgeons to support bone tissue regeneration.
GreenBone
This company produces rattan wood-derived bone substitutes for adult patients undergoing orthopedic surgery to treat severe bone defects and fractures.
